📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Nasal Administration and Plasma Pharmacokinetics of Parathyroid Hormone Peptide PTH 1-34 for the Treatment of Osteoporosis. (2019)

First Author: Pearson RG

Attributed to: PTH nasal delivery for the treatment of osteoporosis - TSB NINTTO funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/pharmaceutics11060265

PubMed Identifier: 31181662

Publication URI: http://europepmc.org/abstract/MED/31181662

Type: Journal Article/Review

Volume: 11

Parent Publication: Pharmaceutics

Issue: 6

ISSN: 1999-4923